InfluAlpha

ABBV

AbbVie Inc. Common Stock NYSE

Last close $264.48 as of 21 Sep 2026
Avg call return
+8.8%
+4.9% vs. index
Scored calls
10
Channels
7
Win Rate
100%
Side taken
10Buy 0Sell

10 scored calls · 7 channels · first tracked 25 Dec 2025

ABBV: tracked call record. Across the full tracked record, 10 of 10 published calls are scored, with an average call return of 8.84%. Scored calls were published from 25 Dec 2025 to 02 Sep 2026, measured from each entry price to its latest available close (price dates: 21 Sep 2026 to 21 Sep 2026). Average benchmark excess is 4.86 percentage points, based on 10 of the 10 scored calls only. Unscored calls are excluded from averages. Holding periods and price freshness vary. These are averages of directional call returns, not an investable portfolio return; fees, dividends and execution costs are not included.

Who is calling ABBV

Last 12 months · 7 buying · 0 selling

  1. 01 Mark Roussin, CPA Buy Calls 2 Return +24.2% Show calls
    1. 05 May 2026 Buy Entry $206.11 Now $264.48 +28.3% vs. index +23.1%

      AI-extracted call. Cite this call

      I believe the $200 level or less is a compelling entry point for this great company.
    2. 10 Jan 2026 Buy Entry $220.08 Now $264.48 +20.2% vs. index +10.4%

      AI-extracted call. Cite this call

      stock number seven, which is going to be AVY, stock ticker ABBV... Analysts are still upbeat on the stock, rating it a buy
    Full record for Mark Roussin, CPA
  2. 02 CNBC Television Buy Calls 1 Return +8.3% Show calls
    1. 15 Jul 2026 Buy Entry $244.22 Now $264.48 +8.3% vs. index +7.4%

      AI-extracted call. Cite this call

      Abby is doing fabulously. I want you to buy it.
    Full record for CNBC Television
  3. 03 MarketBeat Buy Calls 2 Return +8.1% Show calls
    1. 02 Sep 2026 Buy Entry $261.72 Now $264.48 +1.1% vs. index +1.5%

      AI-extracted call. Cite this call

      Probably my favorite name in healthcare, especially for those seeking income, is ABV, ticker symbol is ABBV.
    2. 25 Dec 2025 Buy Entry $229.89 Now $264.48 +15.0% vs. index +4.7%

      AI-extracted call. Cite this call

      Abby is a buy and hold. It's a it's it's a must own buy and hold stock.
    Full record for MarketBeat
  4. 04 TheStreet Buy Calls 1 Return +6.6% Show calls
    1. 13 Jul 2026 Buy Entry $248.00 Now $264.48 +6.6% vs. index +5.0%

      AI-extracted call. Cite this call

      but so is AbbVie.
    Full record for TheStreet
  5. 05 Blue Cloud Trading Buy Calls 2 Return +2.5% Show calls
    1. 24 Jul 2026 Buy Entry $259.29 Now $264.48 +2.0% vs. index −1.1%

      AI-extracted call. Cite this call

      This is an absolute ad right now at 15 times earnings, 3% dividend yield.
    2. 23 Jul 2026 Buy Entry $256.92 Now $264.48 +2.9% vs. index −0.2%

      AI-extracted call. Cite this call

      ABV, Sky Rizzy, and Renvo continue to be the growth drivers for this stock. I like this one here.
    Full record for Blue Cloud Trading
  6. 06 Let's Talk Money! with Joseph Hogue, CFA Buy Calls 1 Return +2.0% Show calls
    1. 26 Jul 2026 Buy Entry $259.36 Now $264.48 +2.0% vs. index −1.1%

      AI-extracted call. Cite this call

      drug maker AbbVie ticker ABBV which trades for 18 times earnings even after it's 35% run.
    Full record for Let's Talk Money! with Joseph Hogue, CFA
  7. 07 Dividend Talks Buy Calls 1 Return +2.0% Show calls
    1. 26 Jul 2026 Buy Entry $259.36 Now $264.48 +2.0% vs. index −1.1%

      AI-extracted call. Cite this call

      a very respectable buy rating from Wall Street.
    Full record for Dividend Talks

Every video calling ABBV

ABBV Community Chat

LIVE

No messages yet. Be the first to share your take on ABBV!

Understand these figures or report an error: Methodology Corrections policy